Chemical and explosives business ORI has endured a really tough year falling -16.7% in a rising market and the decline since late 2019 has actually been far worse. The company has struggled this year due to COVID disruptions, adverse currency moves and geopolitical issues i.e. the trifecta of bad news. We like this business as a recovery story for the year ahead but we wouldn’t be throwing the kitchen sink just yet leaving room to average if we see further declines down towards $12.50.
scroll
Performance update for March, stocks that drove returns & our current positioning
Close
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Close
Market Matters Research Lead Shawn Hickman with David Koch
Close
MM likes into current weakness
Add To Hit List
Related Q&A
Relevant suggested news and content from the site
Video
WATCH
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Podcast
LISTEN
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Daily Podcast Direct from the Desk
Video
WATCH
Market Matters Research Lead Shawn Hickman with David Koch
Recorded Monday 25th March
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.